Approaching Protein Barriers: Emerging Mechanisms of Replication Pausing in Eukaryotes

被引:12
|
作者
Shyian, Maksym [1 ]
Shore, David [1 ]
机构
[1] Univ Geneva, Dept Mol Biol, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland
关键词
fork pausing complex; replication fork; replication fork barrier (RFB); replication fork slowdown; MTC (Mrc1-Tof1-Csm3); topoisomerase I (Top1); topoisomerase II (Top2); RIBOSOMAL DNA REPEATS; SACCHAROMYCES-CEREVISIAE; FORK PROGRESSION; S-PHASE; HOMOLOGOUS RECOMBINATION; PROTECTION COMPLEX; CLEAVAGE COMPLEXES; STRAND SYNTHESIS; GENETIC-ANALYSIS; LEADING-STRAND;
D O I
10.3389/fcell.2021.672510
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
During nuclear DNA replication multiprotein replisome machines have to jointly traverse and duplicate the total length of each chromosome during each cell cycle. At certain genomic locations replisomes encounter tight DNA-protein complexes and slow down. This fork pausing is an active process involving recognition of a protein barrier by the approaching replisome via an evolutionarily conserved Fork Pausing/Protection Complex (FPC). Action of the FPC protects forks from collapse at both programmed and accidental protein barriers, thus promoting genome integrity. In addition, FPC stimulates the DNA replication checkpoint and regulates topological transitions near the replication fork. Eukaryotic cells have been proposed to employ physiological programmed fork pausing for various purposes, such as maintaining copy number at repetitive loci, precluding replication-transcription encounters, regulating kinetochore assembly, or controlling gene conversion events during mating-type switching. Here we review the growing number of approaches used to study replication pausing in vivo and in vitro as well as the characterization of additional factors recently reported to modulate fork pausing in different systems. Specifically, we focus on the positive role of topoisomerases in fork pausing. We describe a model where replisome progression is inherently cautious, which ensures general preservation of fork stability and genome integrity but can also carry out specialized functions at certain loci. Furthermore, we highlight classical and novel outstanding questions in the field and propose venues for addressing them. Given how little is known about replisome pausing at protein barriers in human cells more studies are required to address how conserved these mechanisms are.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Biological Roles and Functional Mechanisms of Arenavirus Z Protein in Viral Replication
    Wang, Jialong
    Danzy, Shamika
    Kumar, Naveen
    Ly, Hinh
    Liang, Yuying
    JOURNAL OF VIROLOGY, 2012, 86 (18) : 9794 - 9801
  • [32] The Structure of the Infectious Prion Protein Constrains Potential Prion Replication Mechanisms
    Wille, Holger
    Requena, Jesils R.
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 228A - 228A
  • [33] ENZYMIC EDITING MECHANISMS IN PROTEIN-SYNTHESIS AND DNA-REPLICATION
    FERSHT, AR
    TRENDS IN BIOCHEMICAL SCIENCES, 1980, 5 (10) : 262 - 265
  • [34] Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains
    Caughey, B
    BRITISH MEDICAL BULLETIN, 2003, 66 : 109 - 120
  • [35] Absence of Non-histone Protein Complexes at Natural Chromosomal Pause Sites Results in Reduced Replication Pausing in Aging Yeast Cells
    Cabral, Marleny
    Cheng, Xin
    Singh, Sukhwinder
    Ivessa, Andreas S.
    CELL REPORTS, 2016, 17 (07): : 1747 - 1754
  • [36] A cellular restriction factor blocking replication of an emerging bunyavirus in human cells: clues for cross-species barriers?
    Varela, Mariana
    Piras, Ilaria
    McLees, Angela
    Mullan, Catrina
    Arnaud, Frederick
    Shi, Xiaohong
    Schnettler, Esther
    Kohl, Alain
    Elliott, Richard
    Palmarini, Massimo
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 : 56 - 56
  • [37] Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease
    Anderson, Mark E.
    Higgins, Linda S.
    Schulman, Howard
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (08): : 437 - 445
  • [38] Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease
    Mark E Anderson
    Linda S Higgins
    Howard Schulman
    Nature Clinical Practice Cardiovascular Medicine, 2006, 3 : 437 - 445
  • [39] Mycobacterium tuberculosis RecG Protein but Not RuvAB or RecA Protein Is Efficient at Remodeling the Stalled Replication Forks IMPLICATIONS FOR MULTIPLE MECHANISMS OF REPLICATION RESTART IN MYCOBACTERIA
    Thakur, Roshan Singh
    Basavaraju, Shivakumar
    Khanduja, Jasbeer Singh
    Muniyappa, K.
    Nagaraju, Ganesh
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (40) : 24119 - 24139
  • [40] Australians' experience, barriers and willingness towards consuming edible insects as an emerging protein source
    Hopkins, Indee
    Farahnaky, Asgar
    Gill, Harsharn
    Newman, Lisa P.
    Danaher, Jessica
    APPETITE, 2022, 169